NCT05439772View on ClinicalTrials.gov

Examining the Effect of Ondansetron on Bowel Prep Success

PHASE4CompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

July 1, 2023

Study Completion Date

July 1, 2023

Conditions
Abdominal PainInflammatory Bowel DiseasesEosinophilic GastroenteritisDiarrheaHematocheziaWeight Loss
Interventions
DRUG

Ondansetron

Patient will take one dissolvable tablet of ondansetron prior to initiating PEG consumption.

Trial Locations (1)

11203

SUNY Downstate University Hospital of Brooklyn, Brooklyn

All Listed Sponsors
lead

State University of New York - Downstate Medical Center

OTHER

NCT05439772 - Examining the Effect of Ondansetron on Bowel Prep Success | Biotech Hunter | Biotech Hunter